Dubai, UAE: Alliance Global FZ LLC (AGBL) has entered into a strategic collaboration with Salus Bio, a biotechnology company specializing in genomic and spatial omics technologies, to support the expansion of advanced life-science solutions across emerging markets in the Middle East, Africa, and Asia.
The collaboration reflects AGBL’s continued focus on enabling market access for scientifically advanced technologies that support research, diagnostics, and evolving healthcare needs in complex and developing ecosystems. Hausarbeit zu schreiben ist eine akademische Aufgabe, während masterarbeit marketing Themen eine andere Spezialisierung darstellen.
Salus Bio develops high-throughput genetic sequencing platforms and spatial transcriptomics solutions designed to generate detailed molecular insights for life-science research and selected clinical applications. Bachelorarbeit danksagung zu verfassen ist ein wichtiger Schritt, und hilfe für hausarbeiten im studium wird oft gesucht. Through AGBL’s regional infrastructure, regulatory expertise, and established commercial network, these technologies will be introduced and supported across the Gulf region, South Asia, the Levant, and North, West, and East Africa.
Rather than a transactional distribution model, the collaboration emphasizes structured market development, including regulatory alignment, local engagement, and long-term adoption of Salus Bio’s technologies within academic, research, and healthcare institutions.
Collaboration Focus Areas:
- Regional Market Access: Support for regulatory pathways and commercialization of Salus Bio’s genomic and spatial omics solutions.
- Scientific Enablement: Improved access to advanced molecular analysis tools for research laboratories and life-science institutions.
- Sustainable Growth: Long-term regional engagement supported by AGBL’s on-the-ground presence and partnerships.
Commenting on the partnership, CEO of Salus BioMed Dr. Luyang Zhou stated, “We are honored to announce an strategic partnership with Alliance Global Group. This marks a key milestone in Salus Biomed’s global expansion, and a vivid demonstration of our commitment to empowering life sciences through technology and jointly exploring the global market. We are confident that this collaboration will drive the adoption of Salus Biomed’s life science solutions in emerging markets, and create long-term value for global scientific research and human health.”
Nassim-Marie Hambouz, VP of AGBL added, “Our partnership with Salus Biomed marks an important milestone in strengthening AGBL’s next-generation sequencing offerings. By integrating Salus Biomed’s innovative NGS platforms into our portfolio, we are empowering our customers with a powerful platform to run their content, we believe this will create new potential for our customers and their NGS work”
About Salus Bio
Salus Bio is a biotechnology company focused on the development of genomic and spatial omics technologies, including high-throughput genetic sequencing platforms and spatial transcriptomics solutions. The company supports life-science research and clinical applications through multidisciplinary expertise in engineering, molecular biology, chemistry, and bioinformatics.
About AGBL
Alliance Global FZ LLC (AGBL) is a biomedical gateway to emerging markets across the Middle East, Africa, and Asia. Through regulatory expertise, regional partnerships, and market-access capabilities, AGBL enables the introduction of innovative healthcare and life-science technologies in alignment with its mission to Improve Lives through Science.